Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mexican operating policy change allows generic availability

This article was originally published in Scrip

Executive Summary

The Mexican government has lifted the requirement that pharmaceutical companies operating in the country must have a manufacturing plant in Mexico to use or sell generic versions of AIDS and other drugs. The move, by the Mexican Ministry of Economy, will allow less expensive generic versions of drugs to be available in the country. Patricia Campos, Latin America Bureau Chief for the AIDS Healthcare Foundation (AHF), said the action could "dramatically improve" the lives of many Mexicans. The policy is effective immediately.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts